Europe to consider two centralised OTC switches

20 March 2020 - Deborah Wilkes

Premium

Two applications to switch medicines from prescription to non-prescription status through the European Union’s centralised authorisation procedure are set to be discussed by the Committee for Medicinal Products for Human Use (CHMP).

Click tags below for more information on topics:

Recordati Teva

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: